The Italian retailer Amplifon, which is a customer of both Demant and GN Hearing, has taken a larger chunk of the Chinese retail market.
The firm has started a new joint venture company with a local partner, which Amplifon will own 51 percent of, the Italian firm revealed on Tuesday.
The joint venture will increase Amplifon's presence in the Zheijang province and Southeast China.
"This transaction represents another important step in our journey to build a leading position in the strategic Chinese market, which represents a sizeable medium-term opportunity given the estimated market size and its outstanding growth potential," says CEO Enrico Vita in a press release.
The transaction has already received all the regulatory clearances that are necessary from local authorities, according to Amplifon.
The Italian company is the world's largest retailer of hearing aids with a global market share of around 11 percent.
It has shops in 26 countries and around 9,000 audiologists in its employ.
FDA plans new sales channel for hearing aids in autumn
Sale of hearing aids in the US exceeds 4 million devices for the first time
More from MedWatch
Rumored GN purchase unlikely but not impossible, say analysts
A low value assessment, a high structural value, and no dominant shareholders make GN Group a reasonable investment case for international private equity firms and industrial players. But just how likely is it? Analysts reveal their best bets for what a GN acquisition could look like.
EMA begins analyzing Bavarian Nordic's vaccine against monkeypox
Prior to deciding on a shared European vaccine supply purchase, the European Medicines Agency has begun analyzing the Danish firm’s smallpox vaccine against monkeypox.
Bavarian Nordic eyes European monkeypox approval for smallpox vaccine
Bavarian Nordic’s smallpox vaccine, Jynneos, hasn’t yet been approved for monkeypox in Europe, a fact that hasn’t stopped countries there from lining up to secure vaccine supplies in light of the recent outbreak.
New CFO wants to shake things up at WSA
A mere month into her new job, Marianne Wiinholt, WS Audiology’s fifth chief financial officer since the firm was established through a merger in 2019, is heralding great structural changes.
Chinese patent expiration dates draw closer for Novo Nordisk
In coming years, Novo Nordisk will take blows in the shape of several patents terminating on the second-biggest market for the firm, a Danish media reports.
System Sales Development Consultant - Investment Projects, Merck Millipore 
Clinical Project Manager 
Director for innovative pre-clinical testing unit 
Project Manager & Scrum Master 
Laboratory technician for process development and clinical manufacturing 
Analytical Senior Scientist 
Senior Manager, Clinical Trial Budget 
Innovation Project Manager, Display Unit 
Senior Chemical Safety Advisor 
Clinical Trial Manager for development of in vitro diagnostics 
Account Manager 
(Senior) Drug Substance Specialist 
Senior Project Manager (GMP - Life Science) 
Nordic Medical Affairs Manager 
Clinical Trial Administrator 
Production Director 
CMO Operations Specialist - screening & selection of CMO/CDMO’s 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Key Account Manager, Europe and Asia